| Net Cash Provided by (Used in) Operating Activities |
$29,571,000 |
USD |
40% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$27,319,000 |
USD |
49% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$11,629,000 |
USD |
-45% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
110,000,000 |
shares |
83% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
47,333,000 |
shares |
5.1% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$13,881,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$17,933,000 |
USD |
-49% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$7,812,000 |
USD |
-20% |
Q1 2025 |
Q1 2025 |
| Operating Lease, Liability |
$2,660,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$31,679,000 |
USD |
-67% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$1,146,560,000 |
USD |
7.9% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$9,162,000 |
USD |
0.74% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$332,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Interest Expense |
$47,450,000 |
USD |
36% |
Q1 2024 |
Q1 2024 |